Axovia, an innovative gene therapy company developing disease-transformative medicines for ciliopathies, is a majority-owned subsidiary of Jaguar Gene Therapy, which is backed by Deerfield Management and UCL Technology Fund.
AlbionVC leads a £14m Series A investment into Solidatus, next generation data management platform, alongside HSBC Ventures and Citi.
UCL Technology Fund portfolio company Quell Therapeutics, a biotechnology firm developing engineered T regulatory cell therapies, expands Series A financing to $84 Million.
AlbionVC portfolio company Limitless, announces $10m Series B and adds Genesys as a new investor and technology partner to continue US expansion.
Phasecraft, a UCL Technology Fund portfolio company is taking quantum theory from research to reality, faster. Today it announces the largest seed funding round for a UK quantum computing company from a syndicate of new and existing investors.
Third Space Learning, an EdTech company backed by the UCL Technology Fund, has secured a £4.3m Series A extension from a syndicate of investors to support expansion to the secondary and international markets.
AlbionVC leads Series A extension investment into WeGift, a digital incentives platform whose clients range from global corporates to SMEs, as it reports 317% annual revenue growth.